Cargando…

Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery

BACKGROUND: The surgical procedure for early-stage second primary non-small cell lung cancer (SP-NSCLC) remains controversial, especially for patients with previous lung cancer-directed surgery. This study aims to compare the survival after wedge resection and lobectomy for these patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Congkuan, Lu, Zilong, Li, Donghang, Pan, Shize, Li, Ning, Geng, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399676/ https://www.ncbi.nlm.nih.gov/pubmed/36033457 http://dx.doi.org/10.3389/fonc.2022.890033

Ejemplares similares

Squamous cell carcinoma predicts worse prognosis than adenocarcinoma in stage IA lung cancer patients: A population-based propensity score matching analysis
por: Hao, Bo, et al.
Publicado: (2022)

Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching’s Study
por: Zhang, Bo, et al.
Publicado: (2021)

Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance
por: Pan, Shize, et al.
Publicado: (2022)

Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Systematic analysis of histone acetylation regulators across human cancers
por: Song, Congkuan, et al.
Publicado: (2023)

Survival after lobectomy versus sub-lobar resection in elderly with stage I NSCLC: a meta-analysis
por: Dong, Siyuan, et al.
Publicado: (2019)

Wedge resection plus adequate lymph nodes resection is comparable to lobectomy for small-sized non-small cell lung cancer
por: Ding, Hongdou, et al.
Publicado: (2022)

Segmentectomy or Wedge Resection in Stage IA Lung Squamous Cell Carcinoma and Adenocarcinoma?
por: Li, Guoshu, et al.
Publicado: (2021)

Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review
por: Shi, Yucong, et al.
Publicado: (2021)

Conditional survival rate estimates of lobectomy, segmentectomy and wedge resection for stage IA1 non-small cell lung cancer: A population-based study
por: Fan, Xiaoxi, et al.
Publicado: (2020)

Change in quality of life of stage IA lung cancer patients after sublobar resection and lobectomy
por: Février, Esther, et al.
Publicado: (2020)

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)

Survival and Long-Term Cause-Specific Mortality Associated With Stage IA Lung Adenocarcinoma After Wedge Resection vs. Segmentectomy: A Population-Based Propensity Score Matching and Competing Risk Analysis
por: Zhao, Mengnan, et al.
Publicado: (2019)

Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer
por: Jeon, Hyun Woo, et al.
Publicado: (2014)

Meta-analysis of segmentectomy versus wedge resection in stage IA non-small-cell lung cancer
por: Xue, Wenfei, et al.
Publicado: (2018)

Virtual randomized study comparing lobectomy and particle beam therapy for clinical stage IA non-small cell lung cancer in operable patients
por: Seo, Young-Seok, et al.
Publicado: (2021)

Lobectomy versus segmentectomy for stage IA3 (T1cN0M0) non-small cell lung cancer: a meta-analysis and systematic review
por: Zhang, Wanfei, et al.
Publicado: (2023)

Wedge resection is equal to segmental resection for pulmonary typical carcinoid patients at localized stage: a population-based analysis
por: Yan, Tao, et al.
Publicado: (2019)

Thoracoscopic Lobectomy Versus Sublobar Resection for pStage I Geriatric Non-Small Cell Lung Cancer
por: Lin, Young-Jen, et al.
Publicado: (2022)

Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC
por: Gallina, Filippo Tommaso, et al.
Publicado: (2023)

Mitophagy: A novel perspective for insighting into cancer and cancer treatment
por: Song, Congkuan, et al.
Publicado: (2022)

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patients
por: Detterbeck, Frank C., et al.
Publicado: (2022)

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer
por: Hao, Bo, et al.
Publicado: (2020)

Survival After Lobectomy vs. Sublobar Resection for Stage IA Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study
por: Yu, Xiangyang, et al.
Publicado: (2022)

The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
por: Liu, Zhao, et al.
Publicado: (2021)

Development and validation of machine learning models to predict survival of patients with resected stage-III NSCLC
por: Jin, Long, et al.
Publicado: (2023)

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 1: a guide to decision-making
por: Detterbeck, Frank C., et al.
Publicado: (2022)

Comparison between radiofrequency ablation and sublobar resections for the therapy of stage I non-small cell lung cancer: a meta-analysis
por: Chen, Shuang, et al.
Publicado: (2020)

Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma
por: Hao, Bo, et al.
Publicado: (2022)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

The Survival Advantage of Lobectomy over Wedge Resection Lessens as Health-Related Life Expectancy Decreases
por: Salazar, Michelle C., et al.
Publicado: (2021)

Wedge resection versus lobectomy in T1 lung cancer patients: a propensity matched analysis
por: Moon, Robert J, et al.
Publicado: (2023)

Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes
por: Choe, Jennie K., et al.
Publicado: (2022)

Comparison of lobectomy and sublobar resection for stage I non-small cell lung cancer: a meta-analysis based on randomized controlled trials
por: Lu, Genlin, et al.
Publicado: (2023)

Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy
por: Chen, Ping, et al.
Publicado: (2022)

Real-world survival outcomes of wedge resection versus lobectomy for cT1a/b cN0 cM0 non-small cell lung cancer: a single center retrospective analysis
por: Bertolaccini, Luca, et al.
Publicado: (2023)

The efficacy and safety of wedge resection for peripheral stage IA lung adenocarcinoma: a real-world study based on a single center
por: Bian, Dongliang, et al.
Publicado: (2023)

Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population-Based Study
por: Song, Congkuan, et al.
Publicado: (2020)

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablation
por: Park, Henry S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mh9rrnmn77oqqntocd9i5jbls1